Open Menu Open Menu

    St. Thomas Law Review

    Health Care

    FeaturedHealth CarePrivacyPublic Health

    From Sleep Scores to State Surveillance: The Oura-DoD Connection

    November 4, 2025By Marcela Rivera

    Oura Health Oy, the Finnish company behind the wildly popular Oura Ring, has recently announced an expanded partnership with the United States Department of Defense (“DoD”).[i] The news sparked a wave of public concern over the ramifications of government involvement with individuals most intimate biometric data.[ii] Marketed as a lifestyle tool for better sleep and […]

    Read More

    Employment LawFeaturedHealth CareMental Health

    Sleepless in Scrubs: Learning from Europe to Protect Patients and Physicians

    October 29, 2025By Sofia Ramirez

    Each year, escalating burnout and untreated depression drive more than 400 physicians to die by suicide.[i]  Before 1984, resident physicians often worked 90–100-hour work weeks with 24–36-hour on-call shifts.[ii]  Reform only gained traction after the highly publicized death of Liby Zion in 1984, whose care lied in the hands of sleep-deprived, overworked residents.[iii]  In response, […]

    Read More

    Constitutional LawFederal Trade CommissionFirst AmendmentHealth Care

    Pretty Dangerous: Commercial Speech, Beauty Product Advertising, and the First Amendment

    September 26, 2025By Jordan Basit

    The modern beauty industry occupies a curious position at the intersection of constitutional law, consumer protection, and gendered health risks. Advertising for cosmetics, whether glossy television spots or viral TikTok endorsements, enjoys robust protection under the First Amendment as commercial speech. Yet this protection often shields marketing for products later revealed to contain toxic ingredients […]

    Read More

    Contract LawFeaturedHealth CarePharmaceuticals

    House Blocks Chinese Biotech: Great Wall Built, but Who Guarded the Supply Chain?

    October 21, 2024By Chelsea Barcenas

      On September 9, 2024, the U.S. House of Representatives voted 306-81 in favor of H.R. 8333, known as the Biosecure Act.[i]  The Biosecure Act prohibits U.S. companies from entering into contracts with biotechnology “companies of concern” and their U.S. subsidiaries.[ii] Specifically, the bill blocks partnerships with BGI Group, MGI, WuXi AppTec, WuXi Biologics, and […]

    Read More

    Back to Top